All lobbying filings
LMH STRATEGIC SOLUTIONS
LMH STRATEGIC SOLUTIONS filed a Q4 report for TRAVERE THERAPEUTICS, INC. on January 12, 2026, reporting $30,000 in lobbying income.
Lobbying for TRAVERE THERAPEUTICS, INC. · Biopharmaceutical company.
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 12, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
California
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Lobbying activity
1
Monitored Most-Favored Nation (MFN).